Hover a dot or row, or tab through the dots · bars scaled to the largest round ($120M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-594134
First filed2026-08-13
Latest2026-08-13
Sought$177M
Sold$39.4M
Investors23
Exemptions506(b)
021-538655
First filed2025-02-19
Latest2025-02-19
Sought$200M
Sold$80M
Investors21
Exemptions506(b)
021-490715
First filed2023-08-25
Latest2023-08-25
Sought$200M
Sold$120M
Investors21
Exemptions506(b)
021-370229
First filed2020-07-06
Latest2021-01-22
Sought$42M
Sold$15.5M
Investors15
Exemptions506(b)
021-326332
First filed2018-11-21
Latest2018-11-21
Sought$8M
Sold$8M
Investors3
Exemptions506(b)
021-276135
First filed2016-12-13
Latest2016-12-13
Sought$2.3M
Sold$2.3M
Investors4
Exemptions506(b)
Who backs Abcuro, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-08-13
Related persons
Name
Relationship
John Alexander Martin
RelationshipExecutive Officer, Director
Mark Pruzanski
RelationshipDirector
Ron Hunt
RelationshipDirector
Michael Dybbs
RelationshipDirector
Ming Fang
RelationshipDirector
Sarah Boyce
RelationshipDirector
Facts
As its latest Form D states them
Industry
Biotechnology
State
Massachusetts (MA)
Exemptions
Rule 506(b)
First filed
2016-12-13
Latest filing
2026-08-13
Who backs Abcuro, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)